CN Patent

CN105582008A — 一种含有维格列汀和二甲双胍的组合物及其制备方法

Assigned to Centaurus Biopharma Co Ltd · Expires 2016-05-18 · 10y expired

What this patent protects

本发明公开了一种维格列汀和二甲双胍的组合物及其制备方法，该组合物含以干重计大于20％的粘合剂，其中二甲双胍以流化床热熔制粒方式制备。所提供组合物改善了二甲双胍和维格列汀的可压性及流动性，该工艺操作简便，生产成本低，环保高效。所制备的复方片剂脆碎度合格、溶出迅速。

USPTO Abstract

本发明公开了一种维格列汀和二甲双胍的组合物及其制备方法，该组合物含以干重计大于20％的粘合剂，其中二甲双胍以流化床热熔制粒方式制备。所提供组合物改善了二甲双胍和维格列汀的可压性及流动性，该工艺操作简便，生产成本低，环保高效。所制备的复方片剂脆碎度合格、溶出迅速。

Drugs covered by this patent

Patent Metadata

Patent number
CN105582008A
Jurisdiction
CN
Classification
—
Expires
2016-05-18
Drug substance claim
No
Drug product claim
No
Assignee
Centaurus Biopharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.